Optimal Infliximab and Biosimilar Dosage and Infusion Frequency for Hidradenitis Suppurativa Control
Location
Virtual
Event Website
https://www.medschool.lsuhsc.edu/genetics/2024_medical_student_research_poster_symposium.aspx
Presentation Date
5-11-2024 12:00 PM
Recommended Citation
Gelis, Camille, "Optimal Infliximab and Biosimilar Dosage and Infusion Frequency for Hidradenitis Suppurativa Control" (2024). Medical Student Research Poster Symposium. 38.
https://digitalscholar.lsuhsc.edu/sommrd/2024MSRD/Posters/38
COinS
Nov 5th, 12:00 PM
Optimal Infliximab and Biosimilar Dosage and Infusion Frequency for Hidradenitis Suppurativa Control
Virtual
https://digitalscholar.lsuhsc.edu/sommrd/2024MSRD/Posters/38
Comments
Mentor: Dr, Christopher J Haas, MD LSUHSC, Department of Dermatology